Merck & Company Inc
Stock Chart, Company Information, and Scan Results
$127.50(as of Jul 17, 4:03 PM EST)
Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.
Merck & Company Inc Company Information, Fundamentals, and Technical Indicators
Stock Price$127.50
Ticker SymbolMRK
ExchangeNyse
SectorHealthcare
IndustryDrug Manufacturers - General
Employees73,000
CountyUSA
Market Cap$315,964.7M
EBIDTA29,517.0M
10-Day Moving Average125.59
P/E Ratio35.31
20-Day Moving Average123.91
Forward P/E Ratio24.51
50-Day Moving Average118.77
Earnings per Share3.55
200-Day Moving Average107.93
Profit Margin-26.03%
RSI58.47
Shares Outstanding2,469.8M
ATR3.56
52-Week High130.29
Volume12,401,325
52-Week Low74.18
Book Value45,931.0M
P/B Ratio6.87
Upper Keltner131.92
P/S Ratio4.81
Lower Keltner115.90
Debt-to-Equity Ratio131.92
Next Earnings Date08/04/2026
Cash Surplus-21,618.0M
Next Ex-Dividend DateUnknown
This pharmaceutical company is responsible for one of the best-selling drugs worldwide. Their blockbuster drug, Keytruda, is designed to treat certain types of cancer and is the company’s main revenue driver. They are also behind the development of Gardasil—a vaccine for HPV that has helped prevent hundreds of thousands of cases of cervical cancer.
Join Our Free Email List
Get emails from us about ways to potentially make money in the stock market.